gallic acid has been researched along with oxidopamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, PY; Kanasawa, Y; Katori, T; Kume, S; Oka, H; Sawada, S; Suzuki, S; Yamaguchi, K; Yasuda, H | 1 |
| Belton, PS; Lu, Z; Nie, G; Tang, H; Zhao, B | 1 |
| Hong, ZY; Liu, HR; Shi, XR; Zhang, YC; Zhu, YZ | 1 |
| Farbood, Y; Mansouri, SM; Sameri, MJ; Sarkaki, A | 1 |
| Farbood, Y; Mansouri, MT; Naghizadeh, B; Rafeirad, M; Sameri, MJ; Sarkaki, A | 1 |
| Anilakumar, KR; Chandrasekhar, Y; Phani Kumar, G; Ramya, EM | 1 |
| Afşar, E; Ağar, A; Aslan, M; Bülbül, M; Güzelad, Ö; Öğüt, E; Özkan, A; Parlak, H; Sinen, O; Yıldırım, FB | 1 |
7 other study(ies) available for gallic acid and oxidopamine
| Article | Year |
|---|---|
Stimulative effects of TMB-8 and trifluoperazine on pancreatic hormone release.
Topics: Animals; Calcium Channel Blockers; Gallic Acid; Glucagon; Hydroxydopamines; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Oxidopamine; Rats; Rats, Inbred Strains; Somatostatin; Trifluoperazine | 1989 |
Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives.
Topics: Antioxidants; Cell Line, Tumor; Chromatography, High Pressure Liquid; Electrochemistry; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Gallic Acid; Glutathione; Humans; Neuroprotective Agents; Oxidopamine; Reactive Oxygen Species; Structure-Activity Relationship | 2006 |
Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Topics: Animals; Behavior, Animal; Cell Line, Tumor; Cell Survival; Gallic Acid; Humans; Leonurus; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2011 |
Motor disorders and impaired electrical power of pallidal EEG improved by gallic acid in animal model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Antioxidants; Disease Models, Animal; Electroencephalography; Gallic Acid; Globus Pallidus; Humans; Male; Medial Forebrain Bundle; Motor Activity; Movement Disorders; Neuropsychological Tests; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Random Allocation; Rats; Rats, Wistar | 2011 |
Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats.
Topics: Animals; Gallic Acid; Humans; Male; Memory; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Plant Extracts; Rats; Rats, Wistar | 2013 |
Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line.
Topics: Cell Line, Tumor; Cell Survival; Dopaminergic Neurons; Dose-Response Relationship, Drug; Gallic Acid; Humans; Neuroprotective Agents; Oxidative Stress; Oxidopamine | 2018 |
Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.
Topics: Animals; Dopamine; Dopaminergic Neurons; Gallic Acid; Male; Motor Activity; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Tandem Mass Spectrometry; Tyrosine 3-Monooxygenase | 2021 |